Determinants of adherence to non-occupational post HIV exposure prophylaxis
Authors:
- Anne Daguenel-NguyenADAnne Daguenel-Nguyen
- Véronique LebeauVLVéronique Lebeau
- Laurent FonquernieLFLaurent Fonquernie
- Pierre-Marie GirardPGPierre-Marie Girard
- Marie-Caroline MeyohasMMMarie-Caroline Meyohas
- 9 January 2006
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 20 (2) , 291-294
Abstract
We conducted a study on 140 patients who sought advice at hospital after a non-occupational exposure. The full 28-day course of prophylactic antiretroviral therapy was completed by 109 patients. No HIV contamination was observed. Factors associated with suboptimal adherence were African ethnicity [odds ratio (OR) 13.3, 2.02-87.54] and oral sexual intercourse (OR 8.35, 1.66-41.99). Compliance with prophylactic antiretroviral therapy can be increased by addressing social and psychological barriers to adherence.Keywords
This publication has 9 references indexed in Scilit:
- Prophylaxis and follow-up after possible exposure to HIV, hepatitis B virus, and hepatitis C virus outside hospital: evaluation of policy 2000-3BMJ, 2005
- Adherence to Antiretroviral Therapy in HIV-Infected Adults in Soweto, South AfricaAIDS Research and Human Retroviruses, 2004
- Behavioral Impact, Acceptability, and HIV Incidence Among Homosexual Men With Access to Postexposure Chemoprophylaxis for HIVJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Cost-effectiveness of Postexposure Prophylaxis After Sexual or Injection-Drug Exposure to Human Immunodeficiency VirusArchives of internal medicine (1960), 2004
- PEP Talk: Treating Nonoccupational HIV ExposureJAMA, 2003
- Another reality check: the direct costs of providing post-exposure prophylaxis in a population-based programmeAIDS, 2001
- Per-Contact Risk of Human Immunodificiency Virus Tramnsmision between Male Sexual PartnersAmerican Journal of Epidemiology, 1999
- A Case–Control Study of HIV Seroconversion in Health Care Workers after Percutaneous ExposureNew England Journal of Medicine, 1997
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994